Hematology Oncology

Fingerprint Dive into the research topics where Hematology Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Antineoplastic Combined Chemotherapy Protocols Medicine & Life Sciences
Squamous Cell Carcinoma Medicine & Life Sciences
Oropharyngeal Neoplasms Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1981 2018

2 Citations (Scopus)

AHNS Series: Do you know your guidelines? Principles of treatment for locally advanced or unresectable head and neck squamous cell carcinoma

The Education Committee of the American Head and Neck Society (AHNS), Apr 1 2018, In : Head and Neck. 40, 4, p. 676-686 11 p.

Research output: Contribution to journalArticle

Guidelines
Oropharyngeal Neoplasms
Hypopharynx
Oropharynx
Mouth Neoplasms
4 Citations (Scopus)

Bendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma

Flinn, I. W., Thompson, D. S., Boccia, R. V., Miletello, G., Lipman, A., Flora, D., Cuevas, D., Papish, S. & Berdeja, J. G., Feb 1 2018, In : British Journal of Haematology. 180, 3, p. 365-373 9 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Therapeutics
Lymphopenia
Bortezomib
Bendamustine Hydrochloride
84 Citations (Scopus)

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

ATLANTIC Investigators, Apr 1 2018, In : The Lancet Oncology. 19, 4, p. 521-536 16 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Therapeutics
Neoplasms
Protein-Tyrosine Kinases
Fatigue